Amerisource Recalls Mispackaged Adderall XR 30 mg Extended-Release Capsules
Amerisource Health Services is recalling 761 cartons of Adderall XR 30 mg capsules due to unit dose mispackaging where blister cavities may contain more than one capsule.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a packaging error (mispackaging) that could lead to dosing errors, fitting the criteria for a moderate severity recall without reported injuries.
Plain-English summary
Amerisource Health Services is recalling 761 cartons of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules, 30 mg. The product is distributed under NDC 68084-887-32 (carton) and NDC 68084-887-33 (blister). The recall involves specific lots: 152418 (exp. 12/31/16), 153544 (exp. 3/31/17), and 154835 (exp. 5/31/17).
The recall was initiated because of unit dose mispackaging, where blister cavities may contain more than one tablet or capsule. This packaging error poses a risk of patients or caregivers administering an incorrect dose of the medication. The product was distributed nationwide.
Consumers and healthcare providers should check their inventory for the affected NDCs and lot numbers. If the product is found, it should be quarantined and returned to the distributor or manufacturer for credit. Patients should consult their healthcare provider if they have concerns about their medication supply or dosing.
The recalled product
- Product
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 30 mg 20 UD Capsules (5 x 4), Rx, Packaged and Distributed by: American Health Pa
- Manufacturer
- Amerisource Health Services
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 761
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot 152418
- exp. 12/31/16
- lot 153544
- exp. 3/31/17
- lot 154835
- exp. 5/31/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Amerisource Health Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Amerisource Health Services
See all →- HighAmerisource Recalls Paroxetine Tablets Due to Foreign Object Presence
FDA (Drugs) · 2017-11-29
- LowAmerisource Recalls Enalapril Maleate Tablets Due to Stability Failures
FDA (Drugs) · 2017-11-22
- ModerateAmerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-03-22
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
Same hazard · mispackaging
See all →- HighRitz peanut butter cracker sandwiches recalled over undeclared peanut from mispackaging
FDA (Devices) · 2025-12-31
- HighCasa Mamita churro bites recalled after cheese stick found in bag
FDA (Food) · 2025-08-06
- HighRitz peanut butter cracker sandwiches recalled over undeclared peanut from mispackaging
FDA (Food) · 2025-07-30
- HighRitz peanut butter cracker 40 count cartons recalled over undeclared peanut
FDA (Food) · 2025-07-30
- HighRitz cracker sandwich variety packs recalled over undeclared peanut from mispackaging
FDA (Food) · 2025-07-30